PCSK9 and cardiovascular disorder: Pcsk9 encodes an enzyme that regulates low-density lipoprotein (LDL) receptor degradation, and loss-of-function mutations in Pcsk9 are associated with low serum cholesterol levels and reduced risk of cardiovascular disease with no recorded adverse side effects30–32.